First documented human infection with Shamonda virus reported in France, notified to WHO on 20 October 2026
First human Shamonda virus infection confirmed in France; notified to WHO 20 Oct 2026, WHO post 1 Nov 2026; patient was severely immunocompromised and died.
- Urgency
- L3
- 68
- 80
- 50
- 20
- 90
At a glance
France notified WHO on 20 October 2026 of the first documented human infection with Shamonda virus, and WHO posted the notice on 1 November 2026. ECDC and Santé publique France published corroborating reports in October 2026 that the patient was severely immunocompromised and died.
- First human Shamonda virus infection confirmed in France; notified to WHO 20 Oct 2026, WHO post 1 Nov 2026; patient was severely immunocompromised and died.
CHRONOS Wire · November 2 · Alert 11
What happened
France reported the first known human infection with Shamonda virus in October 2026. The patient was severely immunocompromised and died, and WHO posted the notification on 1 November 2026.
Why it matters
This is the first documented human infection with Shamonda virus, so timely reporting and further epidemiologic information are important to assess exposure and public health implications.
CHRONOS Bottom Line
France reported a single human Shamonda virus infection in an individual who was severely immunocompromised and died; the case was notified to WHO on 20 October 2026 and WHO published the notice on 1 November 2026.
Full detail
What changed
Official notices from France, ECDC and WHO document the first confirmed human infection with Shamonda virus in a severely immunocompromised patient in France, reported to WHO on 20 October 2026 and posted by WHO on 1 November 2026.
What is genuinely new
This is the first documented human infection with Shamonda virus, reported by France and posted by WHO on 1 November 2026, with corroborating national and ECDC notices in October 2026.
Detailed analysis
France has notified WHO of a single human infection with Shamonda virus. National and ECDC notices describe the patient as severely immunocompromised and deceased. The French statement indicates authorities were informed on 7 October 2026, ECDC notes a report on 22 October 2026, and WHO records notification to WHO on 20 October 2026 with a WHO posting on 1 November 2026. The public notices do not provide details on exposure source, potential onward transmission, or broader human risk.
U.S. Impact
U.S. Impact assessment pending.